C07K 5/06113
Asp- or asn-amino acid
Official title: {Asp- or Asn-amino acid}
C07K5/06113 (Asp- or asn-amino acid) appears on 536 US grants and 270 published applications in this corpus.
Search patents in C07K- Granted patents
- 536
- Published applications
- 270
- Assignees
- 233
- Inventors
- 1,046
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 7 | 0 |
| 1977 | 2 | 0 |
| 1978 | 5 | 0 |
| 1979 | 2 | 0 |
| 1980 | 2 | 0 |
| 1981 | 5 | 0 |
| 1982 | 6 | 0 |
| 1983 | 5 | 0 |
| 1984 | 8 | 0 |
| 1985 | 10 | 0 |
| 1986 | 19 | 0 |
| 1987 | 33 | 0 |
| 1988 | 13 | 0 |
| 1989 | 25 | 0 |
| 1990 | 13 | 0 |
| 1991 | 12 | 0 |
| 1992 | 8 | 0 |
| 1993 | 9 | 0 |
| 1994 | 23 | 0 |
| 1995 | 15 | 0 |
| 1996 | 19 | 0 |
| 1997 | 14 | 0 |
| 1998 | 27 | 0 |
| 1999 | 22 | 0 |
| 2000 | 12 | 0 |
| 2001 | 24 | 4 |
| 2002 | 17 | 16 |
| 2003 | 14 | 19 |
| 2004 | 10 | 17 |
| 2005 | 9 | 11 |
| 2006 | 6 | 9 |
| 2007 | 9 | 8 |
| 2008 | 5 | 10 |
| 2009 | 8 | 11 |
| 2010 | 7 | 10 |
| 2011 | 8 | 10 |
| 2012 | 6 | 9 |
| 2013 | 9 | 12 |
| 2014 | 8 | 7 |
| 2015 | 7 | 18 |
| 2016 | 12 | 16 |
| 2017 | 13 | 13 |
| 2018 | 10 | 15 |
| 2019 | 4 | 8 |
| 2020 | 7 | 6 |
| 2021 | 7 | 9 |
| 2022 | 5 | 10 |
| 2023 | 2 | 2 |
| 2024 | 5 | 13 |
| 2025 | 3 | 5 |
| 2026 | 5 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Preparation method, intermediates, and use of cyclic peptide toxin alpha-amanitin and/or amaninamide1 Sep 2026US 12,723,060 B2Inner Mongolia Duhe Innovation R & D Tech Co., Ltd
- PSMA binder and use thereof28 Apr 2026US 12,612,343 B2Shiya Pharmaceutical, Inc
- PSMA imaging agents24 Mar 2026US 12,583,887 B2Siemens Medical Solutions USA, Inc.
- PSMA imaging agents24 Feb 2026US 12,559,521 B2Siemens Medical Solutions USA, Inc.
- Method for producing peptide compound20 Jan 2026US 12,528,834 B2Nissan Chemical Corporation
- Universal abt compounds and uses thereof24 Sep 2026US 2026/0284204 A1Kleo Pharmaceuticals, Inc.
- Thermostable binding scaffolds9 Jul 2026US 2026/0193328 A1Nectagen, Inc.
- Riluzole prodrugs and their use30 Oct 2025US 2025/0332148 A1Biohaven Therapeutics Ltd.
- Preparation method, intermediates, and use of cyclic peptide toxin alpha-amanitin and/or amaninamide11 Sep 2025US 2025/0282826 A1Inner Mongolia Duhe Innovation R & D Technology Co., Ltd
- Phenethylamines and cathinones precursors28 Aug 2025US 2025/0270242 A1Transcend Therapeutics, Inc.
Most cited
By later US patents
- Lipid conjugates of therapeutic peptides and protease inhibitors130US 5,554,728 ANeXstar Pharmaceuticals, Inc. · 1996
- Tetrapyrrole therapeutic agents113US 4,675,338 ANippon Petrochemicals Company, Limited · 1987
- Peptide compounds having substance P antagonism, processes for preparation thereof and pharmaceutical composition comprising the same97US 5,164,372 AFujisawa Pharmaceutical Co., Ltd. · 1992
- CS-1 peptidomimetics, compositions and methods of using the same95US 5,770,573 ACytel Corporation · 1998
- N-substituted derivatives of aspartame useful as sweetening agents83US 5,480,668 A1996